Literature DB >> 8319631

Development of a 32P-postlabeling assay for 7-methylguanines in human DNA.

R Mustonen1, A Försti, P Hietanen, K Hemminki.   

Abstract

The application of a 32P-postlabeling assay for 7-methylguanines in DNA was studied either by labeling the imidazole ring-opened dinucleotide derivatives or by using strong-anion-exchange column chromatography for the adduct enrichment from normal nucleotides. Data showed that 7-methylguanines can be efficiently labeled as dinucleotides when in vitro methylated DNA was first imidazole ring-opened and then digested to the dinucleotide level with deoxyribonuclease I, snake venom phosphodiesterase, and prostatic acid phosphatase. When using ion exchange chromatography for the adduct enrichment, DNA was digested with micrococcal nuclease and spleen phosphodiesterase. Anion exchange chromatography was applied for 7-methylguanine measurements in white blood cell DNA of healthy nonsmokers (n = 17) and patients (n = 4) treated with the methylating drugs procarbazine and decarbazine. We found that the mean level of 7-methylguanine residues in nonsmokers was 2.5 per 10(7) nucleotides. The corresponding level in the patient samples immediately after the drug treatment was 57 per 10(7) nucleotides.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8319631      PMCID: PMC1567011          DOI: 10.1289/ehp.9399233

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  10 in total

1.  Combined high-performance liquid chromatography/32P-postlabeling assay of N7-methyldeoxyguanosine.

Authors:  P G Shields; A C Povey; V L Wilson; A Weston; C C Harris
Journal:  Cancer Res       Date:  1990-10-15       Impact factor: 12.701

2.  DNA methyl-adduct dosimetry and O6-alkylguanine-DNA alkyl transferase activity determinations in rat mammary carcinogenesis by procarbazine and N-methylnitrosourea.

Authors:  L Y Fong; D E Jensen; P N Magee
Journal:  Carcinogenesis       Date:  1990-03       Impact factor: 4.944

3.  Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.

Authors:  M V Reddy; K Randerath
Journal:  Carcinogenesis       Date:  1986-09       Impact factor: 4.944

4.  In vivo formation and repair of O6-methylguanine in human leukocyte DNA after intravenous exposure to dacarbazine.

Authors:  V L Souliotis; V A Boussiotis; G A Pangalis; S A Kyrtopoulos
Journal:  Carcinogenesis       Date:  1991-02       Impact factor: 4.944

5.  Ring-opened 7-methylguanine nucleotides are resistant to nuclease P1 digestion and good substrates to polynucleotide kinase.

Authors:  K Hemminki
Journal:  Carcinogenesis       Date:  1989-09       Impact factor: 4.944

6.  32P-postlabeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents.

Authors:  M V Reddy; R C Gupta; E Randerath; K Randerath
Journal:  Carcinogenesis       Date:  1984-02       Impact factor: 4.944

7.  Measurement by 32P-postlabelling of 7-methylguanine levels in white blood cell DNA of healthy individuals and cancer patients treated with dacarbazine and procarbazine. Human data and method development for 7-alkylguanines.

Authors:  R Mustonen; A Försti; P Hietanen; K Hemminki
Journal:  Carcinogenesis       Date:  1991-08       Impact factor: 4.944

8.  Accumulation of O6-methylguanine in human blood leukocyte DNA during exposure to procarbazine and its relationships with dose and repair.

Authors:  V L Souliotis; S Kaila; V A Boussiotis; G A Pangalis; S A Kyrtopoulos
Journal:  Cancer Res       Date:  1990-05-01       Impact factor: 12.701

9.  32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures.

Authors:  R C Gupta; K Earley
Journal:  Carcinogenesis       Date:  1988-09       Impact factor: 4.944

10.  Genomic 5-methylcytosine determination by 32P-postlabeling analysis.

Authors:  V L Wilson; R A Smith; H Autrup; H Krokan; D E Musci; N N Le; J Longoria; D Ziska; C C Harris
Journal:  Anal Biochem       Date:  1986-02-01       Impact factor: 3.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.